A multistate trial of pharmacy syringe purchase.
Pharmacies are a potential site for access to sterile syringes as a means for preventing human immunodeficiency virus (HIV), but the type and extent of their utility is uncertain. To examine pharmacy syringe purchase, we conducted a standardized, multistate study in urban and rural areas of four states in which attempts to purchase syringes were documented. Of 1,600 overall purchase attempts, 35% were refused. Colorado (25%) and Connecticut (28%) had significantly lower rates of refusal than Kentucky (41%) and Missouri (47%). Furthermore, urban settings had higher rates of refusal (40%) than rural settings (31%, P < .01). Race and gender did not have a consistent impact on rates of refusal. Despite potential advantages of pharmacies as sites for access to sterile syringes, pharmacy purchase of syringes faces significant obstacles in terms of the practices in different jurisdictions.
Compton
Wilson M
WM
National Institute on Drug Abuse, 6001 Executive Boulevard, MSC 9589, Bethesda, MD 20892-9589, USA. wcompton@nida.nih.gov.
Horton
Joe C
JC
Cottler
Linda B
LB
Booth
Robert
R
Leukefeld
Carl G
CG
Singer
Merrill
M
Cunningham-Williams
Renee
R
Reich
Wendy
W
Fortuin Corsi
Karen
K
Staton
Michele
M
Fink
Joseph L
JL
Stopka
Thomas J
TJ
Spitznagel
Edward L
EL
D003132:Commerce; D005260:Female; D015658:HIV Infections; D006801:Humans; D008297:Male; D010594:Pharmacies; D019966:Substance-Related Disorders; D011795:Surveys and Questionnaires; D013594:Syringes / Q000600:supply & distribution*; D014481:United States